|
|
 |
|
Viewing report
|
|
|
|
Market Dynamics: Antipsychotics - A Market Driven by Reformulation
Datamonitor, Oct 2002
The antipsychotic market is moving into a new competitive environment with the forthcoming launches of new formulations. Short-term intramuscular (IM) depots of Pfizer’s Geodon (ziprasidone) and Eli Lilly’s Zyprexa (olanzapine) are to reach the market by 2003, targeting acute psychosis. How will the formulations ramp-up prescriptions of the respective oral formulations, and how much pressure will be placed on other antipsychotics to maintain their share of newly diagnosed patients?Key data and market dynamics across the seven leading markets: the US, Japan, Germany, France, Italy, Spain, and the UKSpecial focus on the mixed neurotransmitter receptor antagonists class and how the new formulations will alter the market dynamicsDetailed analysis of the Geodon and Seroquel growth strategies and how they are different from the market leadersFocus on new formulations including a critique of clinical data and market positioningForecast revenues up to 2010 and analysis of impacting factorsEli Lilly’s Zyprexa (olanzapine) has a wide range of products on the market and in development. This will lead to treatment flexibility, and attract physicians to prescribing the brand.Janssen’s Risperdal Consta is highly anticipated by the industry and supported by good clinical trials. The formulation will be targeted towards maintenance therapy a will also ramp-up revenues of the oral formulation.Geodon’s short term IM depot will receive a high uptake and be able to command a high price point. In addition, patients will be switched over to the oral formulation once stabilized.Optimize your knowledge of company strategies in the antipsychotic marketEnhance your sales forecasting ability and future product positioning through identification of market driversUnderstand how reformulations for products already on the market can increase the rate of uptake for all products of the brandReview successful lifecycle management strategies through case studies of Geodon and SeroquelIncrease your competitive intelligence by accessing company profiles and assessments of product performance to 2010
Customers who bought this item also bought
Br Malls Participacoes Sa
Br. Holdings Corporation
The World Market for Butadiene Rubber (BR): A 2009 Global Trade Perspective
The 2009 Import and Export Market for Butadiene Rubber (BR) in Iran
The 2009 Import and Export Market for Butadiene Rubber (BR) in Belarus
The 2009 Import and Export Market for Butadiene Rubber (BR) in Bulgaria
The 2009 Import and Export Market for Butadiene Rubber (BR) in Colombia
The 2009 Import and Export Market for Butadiene Rubber (BR) in Estonia
The 2009 Import and Export Market for Butadiene Rubber (BR) in Slovakia
The 2009 Import and Export Market for Butadiene Rubber (BR) in Turkey
The 2009 Import and Export Market for Butadiene Rubber (BR) in Uruguay
The 2009 Import and Export Market for Butadiene Rubber (BR) in China
|
|
|
|
